119th Congress
S. 5004
Cancer Drug Parity Act of 2026
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Tina Smith(D-MN)
- Introduced
- Jul 15, 2026
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (4)
Original cosponsors (1)
- Jerry Moran (R-KS)
Added later (3)
- Jeff Merkley (D-OR) · Sep 14, 2026
- Richard Blumenthal (D-CT) · Sep 14, 2026
- Tammy Baldwin (D-WI) · Sep 30, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
Latest action(Jul 15, 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 15, 2026 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Jul 15, 2026
Introduced in Senate